<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Glob Health</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Glob Health</journal-id><journal-id journal-id-type="hwp">bmjgh</journal-id><journal-id journal-id-type="publisher-id">bmjgh</journal-id><journal-title-group><journal-title>BMJ Global Health</journal-title></journal-title-group><issn pub-type="epub">2059-7908</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29225928</article-id><article-id pub-id-type="pmc">5717965</article-id><article-id pub-id-type="publisher-id">bmjgh-2016-000264</article-id><article-id pub-id-type="doi">10.1136/bmjgh-2016-000264</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject></subj-group></article-categories><title-group><article-title>Causes of severe visual impairment and blindness in students in schools for the blind in Northwest Ethiopia</article-title></title-group><contrib-group><contrib id="author-52841774" contrib-type="author"><name><surname>Asferaw</surname><given-names>Mulusew</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="author-52842933" contrib-type="author"><name><surname>Woodruff</surname><given-names>Geoffrey</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib id="author-49096585" contrib-type="author"><name><surname>Gilbert</surname><given-names>Clare</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<institution>Univesity of Gondar</institution>, <institution content-type="department">Department of Ophthalmology</institution>, <addr-line content-type="city">Gondar</addr-line>, <country>Ethiopia</country>
</aff><aff id="aff2">
<label>2</label>
<institution>University of Leicester</institution>, <institution content-type="department">Department of Ophthalmology</institution>, <addr-line content-type="city">Leicester</addr-line>, <country>UK</country>
</aff><aff id="aff3">
<label>3</label>
<institution content-type="department">Clinical Research</institution>, <institution>London School of Hygiene &#x00026; Tropical Medicine</institution>, <addr-line content-type="city">London</addr-line>, <country>UK</country>
</aff><author-notes><corresp><label>Correspondence to</label> Dr Mulusew Asferaw; <email>muasf@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>10</day><month>6</month><year>2017</year></pub-date><volume>2</volume><issue>2</issue><elocation-id>e000264</elocation-id><history><date date-type="received"><day>05</day><month>12</month><year>2016</year></date><date date-type="rev-recd"><day>17</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjgh-2016-000264.pdf"/><abstract><sec><title>Objectives</title><p>To determine the causes of severe visual impairment and blindness (SVI/BL) among students in schools for the blind in Northwest Ethiopia and to identify preventable and treatable causes.</p></sec><sec><title>Method</title><p>Students attending nine schools for the blind in Northwest Ethiopia were examined and causes assigned using the standard WHO record form for children with blindness and low vision in May and June 2015.</p></sec><sec><title>Results</title><p>383 students were examined, 357 (93%) of whom were severely visually impaired or blind (&#x0003c;6/60 in their better eye). 253 (70.9%) were aged 16 years or above and 228 (63.9%) were males. 100 students aged &#x0003c;16 years were blind and four were SVI, total 104. The major anatomical site of visual loss among those 0-15 years was cornea/phthisis (47.1%), usually due to measles and vitamin A deficiency, followed by whole globe (22.1%), lens (9.6%) and uvea (8.7%). Among students aged 16 years and above, corneal/phthisis (76.3%) was the major anatomical cause, followed by lens (6.3%), whole globe (4.7%), uvea (3.6%) and optic nerve (3.2%). The leading underlying aetiology among students aged &#x0003c;16 years was childhood factors (39.4%) (13.5% measles, 10.6% vitamin A deficiency), followed by unknown aetiology (54.8%), perinatal (2.9%) and hereditary factors (2.9%). In the older group, childhood factors (72.3%) (25% measles, 15% vitamin A deficiency) were major causes, followed by unknown aetiology (24.1%), perinatal (2.4%) and hereditary factors (0.8%). Over 80% of the causes were avoidable with majority being potentially preventable (65%).</p></sec><sec><title>Conclusion</title><p>Corneal blindness, mainly as the result of measles and vitamin A deficiency, is still a public health problem in Northwest Ethiopia, and this has not changed as observed in other low-income countries. More than three-fourth of causes of SVI/BL in students in schools for the blind are potentially avoidable, with measles/vitamin A deficiency and cataract being the leading causes.</p></sec></abstract><kwd-group><kwd>Descriptive study</kwd><kwd>Child health</kwd></kwd-group><funding-group><award-group id="funding-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000367</institution-id><institution>British Council for Prevention of Blindness</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Key questions</title></caption><sec><title>What is already known about this subject?</title><list list-type="bullet"><list-item><p>Corneal scarring has been the leading cause of childhood blindness in low-income countries. However, implementation of programmes to reduce vitamin A deficiency and measles has substantially reduced this cause of blindness with cataract now being the main avoidable cause of blindness in children in many developing countries.</p></list-item></list></sec><sec><title>What are the new findings?</title><list list-type="bullet"><list-item><p>Corneal scarring mainly due to measles and vitamin A deficiency is still the leading causes of blindness in children in schools for the blind in Northwest Ethiopia.</p></list-item></list></sec><sec><title>Recommendations for policy</title><list list-type="bullet"><list-item><p>Policy makers need to implement strategies to control childhood blindness from avoidable causes including measles, vitamin A deficiency, cataract and refractive errors.</p></list-item></list></sec></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>The revised 2010 estimate showed that the number of blind children in the world has declined to 1.26&#x000a0;million compared with the previous estimate in 1999 of 1.4&#x000a0;million. However, in Sub-Saharan Africa, the number of blind children has increased by 31% to 419&#x000a0;000.<xref rid="R1" ref-type="bibr">1</xref> Children who are blind in this region are likely to have a high mortality, but those who survive contribute a disproportionate number of&#x000a0;blind years&#x000a0;of disability. Many of the causes of severe visual impairment and blindness&#x000a0;(SVI/BL) in children are preventable or treatable, and therefore the control of blindness in children is a high priority in the WHO and the&#x000a0;International Agency for the Prevention of Blindness&#x000a0;(IAPB) VISION2020 initiative, the Right to Sight.<xref rid="R2" ref-type="bibr">2</xref>
</p><p>There is a marked regional variation in the prevalence and major causes of childhood blindness in different parts of the world, reflecting varying socioeconomic development and under-5 mortality rates.<xref rid="R3" ref-type="bibr">3</xref> The prevalence ranges from 0.3/1000 children in high-income countries to 1.5/1000 children in low-income countries.<xref rid="R3" ref-type="bibr">3 4</xref> In the poorest countries, corneal scarring due to vitamin A deficiency, measles, ophthalmia neonatorum and the use of traditional practices have been a major cause of blindness, but have declined dramatically in many countries as a result of economic development and more extensive programmes of measles immunisation and better control of vitamin A deficiency. In these settings, cataract is now often the most common avoidable cause of blindness.<xref rid="R5" ref-type="bibr">5</xref> In many middle-income countries, retinopathy of prematurity has become the most common cause, whereas in high-income countries central nervous system disorders and retinal conditions are the most common causes.<xref rid="R5" ref-type="bibr">5</xref>
</p><p>Population-based data on the causes of blindness in children are difficult to obtain, particularly in developing countries like Ethiopia, as registers of the blind do not exist and very large sample sizes are required for formal population-based cross-sectional surveys. Examination of children enrolled in schools for the blind offers the opportunity to examine a large number of children quickly in a standard manner by a few examiners. Over the past 20 years, the WHO classification system, which uses anatomical and aetiological categories of causes and standard recording form, has been increasingly used, which allows data to be compared between studies.<xref rid="R6" ref-type="bibr">6</xref>
</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><p>The study was conducted in nine schools providing special education for blind students in North Gondar, South Gondar and Bahirdar City administrative zones, Amhara regional state in Northwest Ethiopia. Eight of the schools were integrated schools and one, in Gondar city, was a special school for the blind. The study was conducted during May and June 2015. All students under the age of 16 years at the time of the study and aged 16 years and above but who became visually impaired before the age of 16 years were included.</p><p>A team comprising a paediatric ophthalmologist and two trained optometrists undertook the examinations. A brief history of the eye condition, family history, and the&#x000a0;presence of additional impairments (eg, cognitive, physical or hearing impairment and epilepsy) was recorded. Additional relevant information was collected from class teachers and family members. No medical records were available.</p><p>Distance visual acuity was measured by the optometrists using a Snellen E chart at 6 and 3 m, testing each eye separately and then with both eyes open, with current spectacles, if available. Students with profound visual loss were assessed for light projection and perception of light. Visual loss was categorised according to the WHO categories of visual impairment.<xref rid="R6" ref-type="bibr">6</xref> Visual fields were assessed by confrontation, and intraocular pressures were measured using a Tonopen, a handheld applanation tonometer. Anterior segments were examined using a handheld slit&#x000a0;lamp microscope, and posterior segment examination was performed by direct and/or indirect ophthalmoscopy after dilating the pupils with tropicamide&#x000a0;1% eye drops, when possible. Students who needed refraction had retinoscopy after instillation of cyclopentolate&#x000a0;1% eye drops. The WHO classification system was used to categorise the cause of SVI/BL using definitions in the coding instructions. One major anatomical site and the relevant underlying cause of vision loss were selected for each eye and then for each student. The needs for optical, surgical or medical interventions were recorded and the visual prognosis assessed. Students requiring further investigations and treatment were referred to the Department of Ophthalmology, Gondar University Hospital. In addition to providing surgical intervention where indicated, low vision aids and spectacles were provided when required.</p><p>Data were entered into the WHO childhood blindness software V.1.2.75 and analysed with this software and Microsoft Excel. Data are presented on causes at the level of the child.</p><p>Ethical approval was obtained from the Institutional Review Board of the University of Gondar and London School of Hygiene &#x00026; Tropical Medicine. Permission to conduct the research was obtained from appropriate government bodies including regional and zonal education offices and schools. Informed consent was obtained from school heads and parents or legal guardians of students in blind schools. Assent was also obtained from students.</p></sec><sec sec-type="results" id="s3"><title>Results</title><p>A total of 383 students were examined in the nine schools, 244 (63.7%) of whom were male. Their ages ranged from 6 years to 25 years (mean 17.6 years). One hundred and fourteen (30%) students were under the age of 16 years and 269 (70%) were 16 years or above. Additional impairments were identified in nine students (2.4%), which included hearing loss in four, cognitive impairment in two, physical handicap in two and epilepsy in one student. In 17 students, there was a positive family history of visual impairment.</p><p>Sixteen (6.7%) students were not visually impaired or had mild visual impairment and the remainder had severe visual impairment (SVI) (3.4%) or were blind (BL) (89.8%) (<xref ref-type="table" rid="T1">table 1</xref>). Among the 357 students who were SVI/BL, 104 were aged 0-15 years (mean 12.6; range 6-15 years) and 253 were 16 years or above (mean 19.8; range 16-25 years). Among students aged 0-15 years, there were equal numbers of males and females.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Presenting visual status of students attending nine schools for the blind in Northwest Ethiopia by sex and age group</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" rowspan="1" colspan="1">WHO category of visual loss</td><td align="center" rowspan="1" colspan="1">Visual acuity in better eye</td><td colspan="2" rowspan="1">Sex</td><td colspan="4" rowspan="1">Age category in years</td><td rowspan="1" colspan="1">Total</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">Female</td><td align="char" char="&#x000e2;&#x020ac;&#x0201c;" rowspan="1" colspan="1">6-10</td><td align="char" char="&#x000e2;&#x020ac;&#x0201c;" rowspan="1" colspan="1">11-15</td><td align="char" char="&#x000e2;&#x020ac;&#x0201c;" rowspan="1" colspan="1">16-20</td><td align="char" char="&#x000e2;&#x020ac;&#x0201c;" rowspan="1" colspan="1">21-25</td><td align="center" rowspan="1" colspan="1">N (%)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No impairment</td><td align="left" rowspan="1" colspan="1">&#x02265;6/18</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="(" rowspan="1" colspan="1">9&#x000a0;(2.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Visual impairment (VI)</td><td align="left" rowspan="1" colspan="1">&#x0003c;6/18-6/60</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="(" rowspan="1" colspan="1">17&#x000a0;(4.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe visual impairment (SVI)</td><td align="left" rowspan="1" colspan="1">&#x0003c;6/60-3/60</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="(" rowspan="1" colspan="1">13&#x000a0;(3.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Blind (BL)</td><td align="left" rowspan="1" colspan="1">&#x0003c;3/60-PL</td><td align="char" char="." rowspan="1" colspan="1">133</td><td align="char" char="." rowspan="1" colspan="1">63</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">55</td><td align="char" char="." rowspan="1" colspan="1">82</td><td align="char" char="." rowspan="1" colspan="1">48</td><td align="char" char="(" rowspan="1" colspan="1">196&#x000a0;(51.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Blind (BL)</td><td align="left" rowspan="1" colspan="1">NLP</td><td align="char" char="." rowspan="1" colspan="1">85</td><td align="char" char="." rowspan="1" colspan="1">63</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">26</td><td align="char" char="." rowspan="1" colspan="1">79</td><td align="char" char="." rowspan="1" colspan="1">35</td><td align="char" char="(" rowspan="1" colspan="1">148&#x000a0;(38.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">244</td><td align="char" char="." rowspan="1" colspan="1">139</td><td align="char" char="." rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">92</td><td align="char" char="." rowspan="1" colspan="1">182</td><td align="char" char="." rowspan="1" colspan="1">87</td><td align="char" char="(" rowspan="1" colspan="1">383&#x000a0;(100)</td></tr></tbody></table></table-wrap><p>Previous surgical intervention had been performed in 22/383 (5.7%) students: cataract surgery (9), glaucoma surgery (3), enucleation (6), corneal graft (1), optical iridectomy (1) and tarsotomy (1).</p><p>The reported age of onset of visual loss was at birth in 36.5% of students aged 0-15 years and 5.9% among older students aged 16 years and above. Among younger students (under 16 years of age),&#x000a0;38.5% reported becoming blind before the age of 6 years compared with 34.3% of older students. Among younger students, 75% were born blind or became blind before the age of 6 years compared with 40.3% of older students.</p></sec><sec id="s4"><title>Anatomical causes of SVI/BL</title><p>Overall, corneal disease, mainly scarring, staphyloma and phthisis, was the most frequent site leading to visual loss, accounting for 67.8% of SVI/BL (<xref ref-type="table" rid="T2">table 2</xref>). Corneal blindness was more common in older (aged 16 years and above) than younger (under 16 years) students (76.3% and 47.1%,&#x000a0;respectively). Lesions of the whole globe, including anophthalmos and microphthalmos, were the second most frequent causes accounting for 9.8% overall, being a more important cause in younger than older students (22.1% and 4.7%,&#x000a0;respectively). Twenty students (5.6%) were SVI/BL from unoperated cataract and six (1.7%) were still SVI/BL after cataract surgery, with little difference between age groups. Other sites of abnormality leading to visual loss were relatively uncommon, with little difference between age groups.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Anatomical site of abnormality leading to vision impairment in 357 students with SVI/BL in schools for the blind in Northwest Ethiopia by age group</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Anatomical site</td><td valign="top" align="left" rowspan="1" colspan="1">Aged 0-15&#x000a0;years, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Aged 16&#x000a0;years and above, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">Total, n (%)</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Whole globe</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>23&#x000a0;(22.1)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>12&#x000a0;(4.7)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>35&#x000a0;(9.8)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Microphthalmos</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">10&#x000a0;(9.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(3.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">18&#x000a0;(5.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Anophthalmos</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">11&#x000a0;(10.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(1.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">15&#x000a0;(4.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02002;Disorganised</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Glaucoma/buphthalmos</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(1.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Glaucoma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3&#x000a0;(0.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Buphthalmos</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Cornea/phthisis</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>49&#x000a0;(47.1)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>193&#x000a0;(76.3)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>242&#x000a0;(67.8)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Scar</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">22&#x000a0;(21.1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">83&#x000a0;(32.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">105&#x000a0;(29.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Staphyloma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">19&#x000a0;(18.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">55&#x000a0;(21.7)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">74&#x000a0;(20.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Phthisis</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7&#x000a0;(6.7)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">54&#x000a0;(21.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">61&#x000a0;(17.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;&#x02002;Keratoconus</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other opacity</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Lens</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>10&#x000a0;(9.6)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>16&#x000a0;(6.3)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>26&#x000a0;(7.3)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Cataract</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7&#x000a0;(6.7)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">13&#x000a0;(5.1)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">20&#x000a0;(5.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Aphakia/pseudophakia</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3&#x000a0;(2.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3&#x000a0;(1.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">6&#x000a0;(1.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Uvea</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>9&#x000a0;(8.7)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>9&#x000a0;(3.6)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>18&#x000a0;(5.1)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Uveitis</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3&#x000a0;(2.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">5&#x000a0;(2.0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(2.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Coloboma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">17&#x000a0;(4.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">7&#x000a0;(2.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Aniridia</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Retina</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>1&#x000a0;(0.9)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>1&#x000a0;(0.4)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>2&#x000a0;(0.6)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Dystrophy</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Albinism</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Optic nerve</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>5&#x000a0;(4.8)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>8&#x000a0;(3.2)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>13&#x000a0;(3.6)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Atrophy</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">5&#x000a0;(4.8)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(3.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">13&#x000a0;(3.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Globe appears normal</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>5&#x000a0;(4.8)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>12&#x000a0;(4.7)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>17&#x000a0;(4.8)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Refractive error</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(1.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">6&#x000a0;(1.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Amblyopia</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">6&#x000a0;(2.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(2.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Cortical blindness</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Idiopathic nystagmus</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>TOTAL</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>104&#x000a0;(100)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>253&#x000a0;(100)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>357&#x000a0;(100)</bold>
</td></tr></tbody></table></table-wrap></sec><sec id="s5"><title>Aetiology of SVI/BL</title><p>Among 357 students with SVI/BL, the aetiology was classified as 'childhood factors' in 63%, with measles, vitamin A deficiency and other corneal infection/ulcer being the leading underlying causes, accounting for 22%, 14% and 22%,&#x000a0;respectively (<xref ref-type="table" rid="T3">table 3</xref>). Childhood factors were more common causes in the older (16 years and above) than the younger (under 16 years) age group (72.3% and 39.4%, respectively). Perinatal factors, mainly ophthalmia neonatorum, were responsible for only 2.5% of cases and hereditary (1.4%) and intrauterine factors (0.3%) were also uncommon. No student was SVI/BL from retinopathy of prematurity. A third (33%) of cases were classified as being of unknown aetiology which included abnormalities present since birth (15%), cataract (6%), glaucoma (1%) and other (11%). The other category included optic atrophy (3.4%), refractive errors and amblyopia (3.1%). Unknown aetiology was recorded more commonly in younger than in older students (55% and 24%,&#x000a0;respectively).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Aetiological category of visual loss in 357 students with SVI/BL in schools for the blind in Northwest Ethiopia by age group</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Aetiology</td><td valign="top" rowspan="1" colspan="1">Aged 0-15&#x000a0;years, n (%)</td><td valign="top" rowspan="1" colspan="1">Aged 16years and above, n (%)</td><td valign="top" rowspan="1" colspan="1">Total, n (%)</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Hereditary</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>3&#x000a0;(2.9)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>2&#x000a0;(0.8)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>5&#x000a0;(1.4)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Autosomal dominant</td><td valign="top" align="left" rowspan="1" colspan="1">3&#x000a0;(2.9)</td><td valign="top" align="left" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="left" rowspan="1" colspan="1">3&#x000a0;(0.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Autosomal recessive</td><td valign="top" align="left" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Unspecified</td><td valign="top" align="left" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Intrauterinecongenital rubella syndrome</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>0&#x000a0;(0)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>1&#x000a0;(0.4)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>1&#x000a0;(0.3)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Perinatal/Neonatal factor</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>3&#x000a0;(2.9)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>6&#x000a0;(2.4)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>9&#x000a0;(2.5)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Ophthalmia neonatorum</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="left" rowspan="1" colspan="1">6&#x000a0;(2.4)</td><td valign="top" align="left" rowspan="1" colspan="1">8&#x000a0;(2.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Cerebral hypoxia/injury</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Postnatal/childhood factor</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>41&#x000a0;(39.4)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>183&#x000a0;(72.3)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>224&#x000a0;(63)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Measles</td><td valign="top" align="left" rowspan="1" colspan="1">14&#x000a0;(13.5)</td><td valign="top" align="left" rowspan="1" colspan="1">64&#x000a0;(25.3)</td><td valign="top" align="left" rowspan="1" colspan="1">78&#x000a0;(21.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Vitamin A deficiency</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x000a0;(10.6)</td><td valign="top" align="left" rowspan="1" colspan="1">39&#x000a0;(15.4)</td><td valign="top" align="left" rowspan="1" colspan="1">50&#x000a0;(14.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other acquired corneal infection/ulcer</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x000a0;(10.6)</td><td valign="top" align="left" rowspan="1" colspan="1">69&#x000a0;(27)</td><td valign="top" align="left" rowspan="1" colspan="1">79&#x000a0;(22)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Harmful traditional practice</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Trauma</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">8&#x000a0;(3.2)</td><td valign="top" align="left" rowspan="1" colspan="1">9&#x000a0;(2.5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Neoplasm</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(12.5)</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(0.8)</td><td valign="top" align="left" rowspan="1" colspan="1">5&#x000a0;(1.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Unknown aetiology</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>57&#x000a0;(54.8)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>61&#x000a0;(24.1)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>118&#x000a0;(33)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Abnormality since birth</td><td valign="top" align="left" rowspan="1" colspan="1">35&#x000a0;(33.6)</td><td valign="top" align="left" rowspan="1" colspan="1">17&#x000a0;(6.7)</td><td valign="top" align="left" rowspan="1" colspan="1">52&#x000a0;(14.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Cataract</td><td valign="top" align="left" rowspan="1" colspan="1">8&#x000a0;(7.7)</td><td valign="top" align="left" rowspan="1" colspan="1">14&#x000a0;(5.5)</td><td valign="top" align="left" rowspan="1" colspan="1">22&#x000a0;(6.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Glaucoma/buphthalmos</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="left" rowspan="1" colspan="1">2&#x000a0;(0.8)</td><td valign="top" align="left" rowspan="1" colspan="1">4&#x000a0;(1.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other</td><td valign="top" align="left" rowspan="1" colspan="1">12&#x000a0;(11.5)</td><td valign="top" align="left" rowspan="1" colspan="1">28&#x000a0;(11.1)</td><td valign="top" align="left" rowspan="1" colspan="1">40&#x000a0;(11.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Total</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>104&#x000a0;(<bold>100)</bold></bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>253&#x000a0;(<bold>100)</bold></bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>357&#x000a0;(<bold>100)</bold></bold>
</td></tr></tbody></table></table-wrap></sec><sec id="s6"><title>Avoidable causes of SVI/BL</title><p>Over 80% of students had potentially avoidable causes of vision loss, with a higher proportion being preventable (65%) than treatable (15.7%) (<xref ref-type="table" rid="T4">table 4</xref>).&#x000a0;Corneal blindness due to scarring, measles and vitamin A deficiency were the major preventable causes, while cataract, refractive error/amblyopia and uveitis were the major treatable causes. Preventable causes were more common in older (16 years and above) than younger students (74.7% and 41.3%,&#x000a0;respectively), whereas treatable causes were relatively more common in younger students (under 16 years).</p><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Avoidable causes among 357 students with SVI/BL in schools for the blind in Northwest Ethiopia by age group</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Aetiology</td><td valign="top" rowspan="1" colspan="1">Aged 0-15years, n (%)</td><td valign="top" rowspan="1" colspan="1">Aged 16&#x000a0;years and above, n (%)</td><td valign="top" rowspan="1" colspan="1">Total, n (%)</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Preventable conditions</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Corneal scarring</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">11&#x000a0;(10.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">69&#x000a0;(27.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">80&#x000a0;(22.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Measles</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">14&#x000a0;(13.5)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">64&#x000a0;(25.3)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">78&#x000a0;(21.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Vitamin A deficiency</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">11&#x000a0;(10.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">39&#x000a0;(15.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">50&#x000a0;(14)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Trauma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(1.0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(3.2)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">9&#x000a0;(2.5)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Ophthalmia neonatorum</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">6&#x000a0;(2.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(2.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Harmful traditional practice</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(1.0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Autosomal dominant</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Rubella</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Trachoma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Cerebral hyopxia/injury</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(1.0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Subtotal</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>43&#x000a0;(41.3)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>189&#x000a0;(74.7)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>232&#x000a0;(65.0)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Treatable conditions</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/><td valign="top" align="char" char="(" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Cataract</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(7.7)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">14&#x000a0;(5.5)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">22&#x000a0;(6.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Uveitis</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">3&#x000a0;(2.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">5&#x000a0;(2.0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(2.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Refractive error</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(1.6)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">6&#x000a0;(1.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Refractive amblyopia</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">6&#x000a0;(2.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">8&#x000a0;(2.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Glaucoma</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(1.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Corneal scar</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">4&#x000a0;(1.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Vernal keratoconjunctivitis</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(1.9)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">2&#x000a0;(0.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Keratoconus</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.4)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Brain tumour</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(1.0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">0&#x000a0;(0)</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">1&#x000a0;(0.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Subtotal</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>22&#x000a0;(21.1)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>34&#x000a0;(13.4)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>56&#x000a0;(<bold>15.7)</bold></bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Total avoidable</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>65&#x000a0;(62.5)</bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>223&#x000a0;(<bold>88.1)</bold></bold>
</td><td valign="top" align="char" char="(" rowspan="1" colspan="1">
<bold>288&#x000a0;(<bold>80.7)</bold></bold>
</td></tr></tbody></table></table-wrap></sec><sec id="s7"><title>Trends in SVI/BL over time</title><p>To determine possible trends on the pattern of major causes of visual loss, students with SVI/BL were grouped into four age groups: (a) age 6-10 years (n=19), (b)&#x000a0;11-15 years&#x000a0;(n=85), (c)&#x000a0;16-20 years (n=169) and (d) 21-25 years (n=84) (<xref ref-type="fig" rid="F1">figure 1A and B</xref>). Corneal pathologies were the leading cause of SVI/BL in the oldest three groups (b, c, d), while whole globe was the leading cause in the youngest&#x000a0;(a) (<xref ref-type="fig" rid="F1">figure 1A</xref>). The change in aetiology with age reflects these differences with acquired conditions of childhood predominating in the older two age groups (c, d), with an unknown aetiology being more common in the younger two age groups (a, b) (<xref ref-type="fig" rid="F1">figure 1B</xref>). Among childhood factors, measles and vitamin A deficiency were analysed separately. Vitamin A deficiency was responsible for visual loss in 9.5% in students aged 21-25 years, 18.3% in students aged 16-20 years, 11.8% in students aged 11-15 years and 5.3% in students aged 6-10 years, whereas measles was responsible in 23.8%, 26.0%, 15.3% and 5.3% in the same age groups.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Anatomical site (A) and aetiological category (B) of principal abnormality in students of different age groups.</p></caption><graphic xlink:href="bmjgh-2016-000264f01"/></fig><p>The date of onset of visual loss, as recalled by students, was also recorded which allowed the approximate year of onset to be determined. Causes of vision loss were grouped as corneal and non-corneal (<xref ref-type="fig" rid="F2">figure 2</xref>). Corneal blindness was responsible for approximately half of all vision loss for each estimated year of onset.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Recollected date of onset of visual loss of students with severe visual impairment and blindness.</p></caption><graphic xlink:href="bmjgh-2016-000264f02"/></fig></sec><sec id="s8"><title>Treatment and prognosis</title><p>No intervention was needed for most students as they were irreversibly blind. Vision could be improved in 20 right eyes (5.2%) and in 29 left eyes (7.6%).&#x000a0;Visual acuity was expected to deteriorate in 13 (3.4%) right eyes and&#x000a0;11 (2.9%) left eyes. Spectacle prescription was recommended in 22, low vision devices in 13 and surgical intervention, principally cataract surgery and corneal transplantation, was recommended in 33 students. A change in school was recommended for 10 students.</p></sec><sec sec-type="discussion" id="s9"><title>Discussion</title><p>In this study, the majority of students (93%) attending special education were SVI/BL, being similar to the previous study in Ethiopia<xref rid="R7" ref-type="bibr">7</xref> and in Burundi.<xref rid="R8" ref-type="bibr">8</xref> In our study, there were nine students (2.3%) who had visual acuity of 6/18 or better who were inappropriately enrolled in schools for the blind, although the proportion of students with good visual acuity was lower than in some studies.<xref rid="R9" ref-type="bibr">9</xref>
</p><p>In our study, only 30% of students were younger than 16 years, and similar findings have been reported in two studies in Nigeria<xref rid="R10" ref-type="bibr">10 11</xref> where 65% were 16 years or above, and one study in Burundi<xref rid="R8" ref-type="bibr">8</xref> where almost half the students were older than 15 years. The attendance of young adults in schools for the blind may indicate that once a child enters a blind school they tend to stay there, often because of poor academic attainment for several reasons: they often start school very late and miss a lot of schooling, Braille educational materials are often limited, and so students find it harder to learn and reach the level required to progress. In addition, children with SVI/BL may be abandoned by their carers particularly if they are admitted to residential schools. Further studies on the role and impact of education in schools for the blind in Africa are needed.</p><p>Two-thirds of all students in our study had vision loss from corneal scarring or phthisis, which affected almost half of the students under the age of 16 years. This is essentially the same as in the study carried out in Ethiopian schools for the blind 15 years ago in which 62.4% of children aged less than 16 years were SVI/BL from corneal scarring or phthisis<xref rid="R7" ref-type="bibr">7</xref> but is considerably higher than in other studies in Africa for&#x000a0;example, in Burundi (24%),<xref rid="R8" ref-type="bibr">8</xref> Oyo State in Nigeria (29%),<xref rid="R10" ref-type="bibr">10</xref> Cameroon&#x000a0;(32%)<xref rid="R12" ref-type="bibr">12</xref> and East Africa&#x000a0;(19%).<xref rid="R13" ref-type="bibr">13</xref> In contrast, corneal scarring/phthisis was not the main anatomical site in South Eastern Nigeria<xref rid="R11" ref-type="bibr">11</xref> and Uganda,<xref rid="R14" ref-type="bibr">14</xref> being responsible for 21% of visual loss. Lens pathology was the leading anatomical site of vision loss in South Eastern Nigeria (31.4%) and globe pathology (27%) in Uganda. Our findings are similar to a study in 1993 in Zimbabwe in which 67% of children were blind from corneal pathology.<xref rid="R15" ref-type="bibr">15</xref>
</p><p>Recent studies in poor countries in south east Asia have shown a lower proportion of SVI/BL due to corneal scarring than in Africa,<xref rid="R16" ref-type="bibr">16-18</xref> ranging from 5% in Bhutan<xref rid="R16" ref-type="bibr">16</xref> to 8% in South India.<xref rid="R19" ref-type="bibr">19</xref>
</p><p>Data on the underlying aetiology need to be interpreted with caution, as medical records were not available and the diagnosis was made on the clinical appearance, or what students reported.</p><p>In our study, a quarter of students were identified as having had measles or vitamin A deficiency as the principal underlying cause of their vision loss, being similar to recent studies from Asia and Africa. However, a further 10.6% had corneal scarring where an underlying cause could not be determined, where vitamin A deficiency may have contributed to the corneal pathology, so underestimating the relative contribution. Despite an improvement in measles immunisation coverage from 59% in 2005 to 84% in 2014, the incidence of measles infection increased from 0.6 per 100,000 in 2005 to 11.1 per 100,000 in 2014.<xref rid="R20" ref-type="bibr">20</xref> According to the 2011 Ethiopian Demographic and Health Survey (DHS), measles immunisation coverage was only 56% overall, with significant variation between regions.<xref rid="R21" ref-type="bibr">21</xref> Vitamin A deficiency is also a serious public health problem in Ethiopia with a national prevalence of Bitot's spots of 1.7% among children aged 6-71 months, and 37.7% of children had deficient serum retinol levels. In this study, only 22.6% of children had received a vitamin A supplement in the previous 6 months.<xref rid="R22" ref-type="bibr">22</xref> Data from the 2011 DHS also showed that coverage of vitamin A supplementation in the previous 6&#x000a0;months among children aged 6-59 months was suboptimal (54.5% overall) with regional differences ranging from 28% to 83%.<xref rid="R23" ref-type="bibr">23</xref> Children in the poorest households, or whose mothers did not attend antenatal or postnatal care or where the mother had not worked during the previous year had the lowest coverage.</p><p>In our study, 7.7% of children under 16 years and 6.2% of all students had cataract as the principal diagnosis, but only one-third had undergone cataract surgery.&#x000a0;Eighteen per cent of children attending schools for the blind in Kenya, Malawi, Tanzania and Uganda had cataract as the major cause of visual impairment, with 83% of these having had surgery in at least one eye.<xref rid="R24" ref-type="bibr">24</xref> The lower proportion of cataract blindness in our study almost certainly reflects the larger number of children with corneal pathology.</p><p>The number of students in our study, although large, represents only a small minority of the estimated number of young people with SVI/BL in Northwest Ethiopia, which is likely to be approximately 8749, assuming a prevalence of 1/1000 children. Children in schools for the blind may, therefore, not be representative of blind children in the whole population as preschool age children and those with additional impairments, such as cerebral palsy, are likely to be under-represented. In addition, children from remote and underserved parts of the country may not attend a special school.</p><p>Data in this study were collected using the WHO classification and Coding Instructions. This has the advantage of allowing comparison to be made with other studies but major difficulties remain in identifying the underlying aetiology many years after the onset of disease. There were no medical records in any school and relying on the response of students is likely to lead to bias. This is one of the limitations of this study.</p><p>There is inconsistency in the literature regarding how to classify phthisis bulbi, which in low-income settings is often secondary to corneal perforation. In this study, the WHO guidelines were strictly followed and phthisis was classified under corneal pathology rather than whole globe.</p><p>It is difficult to assess trends over time in the aetiology of SVI/BL in this study for several reasons. First, student's recall of the age of onset of their visual loss is likely to be unreliable, and second, children who stay on at school may be different from those who leave at the usual age, so introducing bias. However, it was noted that there was a trend of reduction of measles as the cause of visual loss but there does not seem to be a change in pattern of vitamin A deficiency.</p></sec><sec id="s10"><title>Conclusions and implications</title><p>Corneal blindness, mainly as the result of measles and vitamin A deficiency, is still a public health problem in Northwest Ethiopia, and this has not changed over time as has been observed in other low-income countries. More than three-quarters of the causes of SVI/BL are potentially avoidable, with measles, vitamin A deficiency and cataract being the leading causes.</p><p>Concerted and integrated efforts are needed by the Ministry of Health and other authorities, primary healthcare workers, eye care professionals and educators to implement primary healthcare to prevent corneal blindness from vitamin A deficiency and measles and to increase the detection, referral and management of cataract and refractive error. Initiatives to improve coverage of measles immunisation and enhance vitamin A supplementation are also urgently needed, both of which will reduce under-5 mortality rates as well as vision loss and blindness in children. The WHO recommends one tertiary level child eye health facility per 10&#x000a0;million population,<xref rid="R2" ref-type="bibr">2 4</xref> but currently there are only three for a population of over 90&#x000a0;million in Ethiopia. Strengthening existing facilities and establishing new centres so that there is one in each region of the country are highly recommended to address the treatable causes of childhood blindness.</p></sec></body><back><ack id="ack"><p>The authors wish to thank The British Council for the Prevention of Blindness (BCPB) for funding this study and participant students, school teachers, authorities in education offices of respective zones for their participation and help during data collection. Our heartfelt thanks to Mr Sisay Addisie, the late project co-ordinator, Department of Ophthalmology of Gondar, for his kind support and facilitation of logistics during the fieldwork.</p></ack><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> MA, GW and CG conceived of the study. MA collected the data. MA, GW and CG analysed the data. All the authors contributed to the manuscript and approved the final draft for submission.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None delared.</p></fn><fn fn-type="other"><p><bold>Patient consent:</bold> Obtained.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> IRB of University of Gondar and London School of Hygiene and Tropical Medicine.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Data sharing statement:</bold> No additional data are available.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chandna</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>C</given-names></name></person-group>
<article-title>When your eye patient is a child</article-title>. <source>Community Eye Health</source>
<year>2010</year>;<volume>23</volume>:<fpage>1</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">20523854</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="book">
<collab>WHO</collab>. <source>Preventing blindness in children: report of a WHO/IAPB scientific meeting, Hyderabad, India, 13-17 April 1999</source>: <publisher-name>World Health Organization Geneva</publisher-name>, <year>2000</year>
<comment>WHO/PBL/00.77</comment>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Anderton</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dandona</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prevalence of visual impairment in children: a review of available data</article-title>. <source>Ophthalmic Epidemiol</source>
<year>1999</year>;<volume>6</volume>:<fpage>73</fpage>&#x02013;<lpage>82</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1076/opep.6.1.73.1571">doi:10.1076/opep.6.1.73.1571</ext-link>
<pub-id pub-id-type="pmid">10384686</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name></person-group>
<article-title>Childhood blindness in the context of VISION 2020--the right to sight</article-title>. <source>Bull World Health Organ</source>
<year>2001</year>;<volume>79</volume>:<fpage>227</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">11285667</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Parikshit</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Clare</surname><given-names>G</given-names></name></person-group>
<article-title>Blindness in children: a worldwide perspective</article-title>. <source>Community Eye Health</source>
<year>2007</year>;<volume>20</volume>:<fpage>32</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">17612696</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name>, <string-name>Negrel&#x000a0;<given-names>AD</given-names>
</string-name>, <etal>et al</etal></person-group>
<article-title>Childhood blindness: a new form for recording causes of visual loss in children</article-title>. <source>Bull World Health Organ</source>
<year>1993</year>;<volume>71</volume>:<fpage>485</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">8261552</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kello</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>C</given-names></name></person-group>
<article-title>Causes of severe visual impairment and blindness in children in schools for the blind in Ethiopia</article-title>. <source>Br J Ophthalmol</source>
<year>2003</year>;<volume>87</volume>:<fpage>526</fpage>&#x02013;<lpage>30</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bjo.87.5.526">doi:10.1136/bjo.87.5.526</ext-link>
<pub-id pub-id-type="pmid">12714383</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ruhagaze</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Njuguna</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Kandeke</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Blindness and severe visual impairment in pupils at schools for the blind in Burundi</article-title>. <source>Middle East Afr J Ophthalmol</source>
<year>2013</year>;<volume>20</volume>:<fpage>61</fpage>&#x02013;<lpage>5</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4103/0974-9233.106390">doi:10.4103/0974-9233.106390</ext-link>
<pub-id pub-id-type="pmid">23580854</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tumwesigye</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Msukwa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Njuguna</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Inappropriate enrollment of children in schools for the visually impaired in east Africa</article-title>. <source>Ann Trop Paediatr</source>
<year>2009</year>;<volume>29</volume>:<fpage>135</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1179/146532809X440752">doi:10.1179/146532809X440752</ext-link>
<pub-id pub-id-type="pmid">19460267</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mosuro</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Ajaiyeoba</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Bekibele</surname><given-names>CO</given-names></name>, <etal>et al</etal></person-group>
<article-title>Survey of low vision among students attending schools for the blind in Nigeria: a descriptive and interventional study</article-title>. <source>Middle East Afr J Ophthalmol</source>
<year>2012</year>;<volume>19</volume>:<fpage>382</fpage>&#x02013; <lpage>91</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4103/0974-9233.102744">doi:10.4103/0974-9233.102744</ext-link>
<pub-id pub-id-type="pmid">23248540</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ezegwui</surname><given-names>IR</given-names></name>, <name name-style="western"><surname>Umeh</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Ezepue</surname><given-names>UF</given-names></name></person-group>
<article-title>Causes of childhood blindness: results from schools for the blind in south eastern Nigeria</article-title>. <source>Br J Ophthalmol</source>
<year>2003</year>;<volume>87</volume>:<fpage>20</fpage>&#x02013;<lpage>3</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bjo.87.1.20">doi:10.1136/bjo.87.1.20</ext-link>
<pub-id pub-id-type="pmid">12488255</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Noche</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Bella</surname><given-names>AL</given-names></name></person-group>
<article-title>[Frequency and causes of blindness and visual impairment in schools for the blind in Yaound&#x000e9; (Cameroon)]</article-title>. <source>Sante</source>
<year>2010</year>;<volume>20</volume>:<fpage>133</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1684/san.2010.0202">doi:10.1684/san.2010.0202</ext-link>
<pub-id pub-id-type="pmid">21118789</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Njuguna</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Msukwa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shilio</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Causes of severe visual impairment and blindness in children in schools for the blind in Eastern Africa: changes in the last 14 years</article-title>. <source>Ophthalmic Epidemiol</source>
<year>2009</year>;<volume>16</volume>:<fpage>151</fpage>&#x02013;<lpage>5</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/09286580902738183">doi:10.1080/09286580902738183</ext-link>
<pub-id pub-id-type="pmid">19437309</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Watmon</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Nyathirombo</surname><given-names>A</given-names></name></person-group>
<article-title>Causes of severe visual impairment and blindness in the schools for the blind in the Northern and North Western Uganda</article-title>. <source>JOECSA</source>
<year>2013</year>;<volume>17</volume>:<fpage>6</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schwab</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kagame</surname><given-names>K</given-names></name></person-group>
<article-title>Blindness in Africa: Zimbabwe schools for the blind survey</article-title>. <source>Br J Ophthalmol</source>
<year>1993</year>;<volume>77</volume>:<fpage>410</fpage>&#x02013; <lpage>2</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bjo.77.7.410">doi:10.1136/bjo.77.7.410</ext-link>
<pub-id pub-id-type="pmid">8343467</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Farmer</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Rudkin</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Causes of severe visual impairment and blindness: comparative data from Bhutanese and Laotian schools for the blind</article-title>. <source>Asia Pac J Ophthalmol</source>
<year>2015</year>;<volume>4</volume>:<fpage>350</fpage>&#x02013; <lpage>6</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/APO.0000000000000152">doi:10.1097/APO.0000000000000152</ext-link>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Muhit</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>CE</given-names></name>, <etal>et al</etal></person-group>
<article-title>Causes of severe visual impairment and blindness in Bangladesh: a study of 1935 children</article-title>. <source>Br J Ophthalmol</source>
<year>2007</year>;<volume>91</volume>:<fpage>1000</fpage>&#x02013;<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bjo.2006.108019">doi:10.1136/bjo.2006.108019</ext-link>
<pub-id pub-id-type="pmid">17360736</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Al-Samarraie</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>An update on progress and the changing epidemiology of causes of childhood blindness worldwide</article-title>. <source>J AAPOS</source>
<year>2012</year>;<volume>16</volume>:<fpage>501</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jaapos.2012.09.004">doi:10.1016/j.jaapos.2012.09.004</ext-link>
<pub-id pub-id-type="pmid">23237744</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Krishnaiah</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Subba Rao</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lakshmi Narasamma</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>A survey of severe visual impairment in children attending schools for the blind in a coastal district of Andhra Pradesh in South India</article-title>. <source>Eye</source>
<year>2012</year>;<volume>26</volume>:<fpage>1065</fpage>&#x02013;<lpage>70</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/eye.2012.88">doi:10.1038/eye.2012.88</ext-link>
<pub-id pub-id-type="pmid">22576826</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="book">
<collab>Federal Ministry of Health</collab>. <chapter-title>Ethiopia National expanded programme on immunization</chapter-title>
<source><italic>Comprehensive multi-year plan 2016</italic>-<italic>2020</italic></source>. <publisher-loc>FMOE Addis Ababa</publisher-loc>: <publisher-name>Federal Ministry of Health</publisher-name>, <year>2015</year>.</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lakew</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bekele</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Biadgilign</surname><given-names>S</given-names></name></person-group>
<article-title>Factors influencing full immunization coverage among 12-23 months of age children in Ethiopia: evidence from the national demographic and health survey in 2011</article-title>. <source>BMC Public Health</source>
<year>2015</year>;<volume>15</volume>:<elocation-id>728</elocation-id>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12889-015-2078-6">doi:10.1186/s12889-015-2078-6</ext-link>
<pub-id pub-id-type="pmid">26224089</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Demissie</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mekonen</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Magnitude and distribution of vitamin A deficiency in Ethiopia</article-title>. <source>Food Nutr Bull</source>
<year>2010</year>;<volume>31</volume>:<fpage>234</fpage>&#x02013;<lpage>41</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/156482651003100206">doi:10.1177/156482651003100206</ext-link>
<pub-id pub-id-type="pmid">20707229</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Haile</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Biadgilign</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Azage</surname><given-names>M</given-names></name></person-group>
<article-title>Differentials in vitamin A supplementation among preschool-aged children in Ethiopia: evidence from the 2011 Ethiopian Demographic and Health Survey</article-title>. <source>Public Health</source>
<year>2015</year>;<volume>129</volume>:<fpage>748</fpage>&#x02013;<lpage>54</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.puhe.2015.03.001">doi:10.1016/j.puhe.2015.03.001</ext-link>
<pub-id pub-id-type="pmid">25982948</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Msukwa</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Njuguna</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tumwesigye</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Cataract in children attending schools for the blind and resource centers in Eastern Africa</article-title>. <source>Ophthalmology</source>
<year>2009</year>;<volume>116</volume>:<fpage>1009</fpage>&#x02013;<lpage>12</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2008.12.020">doi:10.1016/j.ophtha.2008.12.020</ext-link>
<pub-id pub-id-type="pmid">19410959</pub-id></mixed-citation></ref></ref-list></back></article>